Skip to main content
. 2021 Aug 10;22(6):214. doi: 10.1208/s12249-021-02089-5

Table II.

Repurposing Some Drugs Against COVID-19 Treatment

graphic file with name 12249_2021_2089_Tab2a_HTML.jpg

graphic file with name 12249_2021_2089_Tab2b_HTML.jpg

graphic file with name 12249_2021_2089_Tab2c_HTML.jpg

graphic file with name 12249_2021_2089_Tab2d_HTML.jpg

graphic file with name 12249_2021_2089_Tab2e_HTML.jpg

graphic file with name 12249_2021_2089_Tab2f_HTML.jpg

graphic file with name 12249_2021_2089_Tab2g_HTML.jpg

graphic file with name 12249_2021_2089_Tab2h_HTML.jpg

graphic file with name 12249_2021_2089_Tab2i_HTML.jpg

graphic file with name 12249_2021_2089_Tab2j_HTML.jpg

graphic file with name 12249_2021_2089_Tab2k_HTML.jpg

graphic file with name 12249_2021_2089_Tab2l_HTML.jpg

graphic file with name 12249_2021_2089_Tab2m_HTML.jpg

graphic file with name 12249_2021_2089_Tab2n_HTML.jpg

graphic file with name 12249_2021_2089_Tab2o_HTML.jpg

graphic file with name 12249_2021_2089_Tab2p_HTML.jpg

graphic file with name 12249_2021_2089_Tab2q_HTML.jpg

graphic file with name 12249_2021_2089_Tab2r_HTML.jpg

graphic file with name 12249_2021_2089_Tab2s_HTML.jpg